Zobrazeno 1 - 10
of 26
pro vyhledávání: '"H K, Berthold"'
Autor:
A. Kwetkat, A. Agustí, J. A. Serra Rexach, H. K. Berthold, U. Sommeregger, J. F. Macías Núñez, T. Frühwald, T.J.M. van der Cammen, R. Mateos, R. W. M. M. Jansen, P. Mierzejewski, Miles D. Witham, C. Hughes, H. Frohnhofen, P. Robert, C. Gisinger, J. J. Solano Jaurrieta, J. Sławek, P. Dovjak, M. Broncel, W. von Renteln-Kruse, Heinrich Burkhardt, Alessandro Mugelli, Alicja Klich-Rączka, B. S. Husebø, Michael Denkinger, Juergen M. Bauer, A. Zeyfang, M. Marcucci, M. Hüll, P. M. L. A. van den Bemt, C. Annweiler, Farhad Pazan, Roy L. Soiza, S. Schwarz, B. Bień, C. Schindler, H. Gutzmann, A. San-José Laporte, S. Kasper, John R.F. Gladman, E. Ekpo, T. Eriksson, M. Schuler, Christel Weiss, M. Laville, Kristina Johnell, C. Ashton, R. J. Schulz, A. J. Cruz Jentoft, R. Huupponen, M. Gogol, Martin Wehling, Graziano Onder, M. Gosch, A. H. Ranhoff, U. Wedding, Tomasz Grodzicki, Stefano Volpato, Carmelinda Ruggiero, T. Kostka, I. Heuser, B. Iglseder, Antonio Cherubini, Peter Crome, Denis O'Mahony, S. Ruths, L. Rodríguez Mañas, Raffaele Antonelli Incalzi, C. Mouchoux, Katarzyna Wieczorowska-Tobis, S. Byrne, M. Rhalimi
Publikováno v:
Drugs & Aging. 35(7)
In the original publication of this article, the members of the FORTA group were provided in such a way that they could not be indexed as collaborators on PubMed. The article should have included an Acknowledgement section as shown below.
Autor:
Ioanna Gouni-Berthold, H K Berthold
Publikováno v:
Current Medicinal Chemistry. 22:3580-3596
Cardiovascular disease (CVD) is a leading cause of death for both women and men. Common traditional risk factors for CVD, such as hypercholesterolemia, hypertension and smoking have a high prevalence in women and in some cases a greater health impact
Autor:
Ioanna Gouni-Berthold, H K Berthold
Publikováno v:
Current Pharmaceutical Design. 17:3690-3698
Evidence suggests that patient gender is associated with the quality of care provided in the treatment of cardiometabolic diseases. The majority of findings suggest that female patients receive less intensified care than male patients. However, the q
Autor:
H K Berthold, Ioanna Gouni-Berthold
Publikováno v:
Current Pharmaceutical Design. 17:950-960
New studies further demonstrate that lowering low-density lipoprotein (LDL)-cholesterol, at least with the use of statins, decreases the risk of cardiovascular disease (CVD). Subsequently national and international guidelines have set target levels f
Pharmakovigilanz: Empfehlungen zur Meldung unerwünschter Arzneimittelwirkungen durch die Ärzteschaft
Autor:
H. K. Berthold, G. Schott
Publikováno v:
ZFA - Zeitschrift für Allgemeinmedizin. 81:327-334
Autor:
H K, Berthold
Publikováno v:
Der Internist. 55(1)
The new oral anticoagulants (NOAC) are alternative drugs to classical vitamin K antagonists (VKA) for stroke prevention in patients with nonvalvular atrial fibrillation. They have been shown in randomized trials to be superior to warfarin in reducing
Autor:
Peter D. Klein, Ronna G. Miller, Farook Jahoor, Peter J. Reeds, Linda Wykes, Tamir H. Keshen, Douglas G. Burrin, Tom Jaksic, H. K. Berthold, Barbara Stoll, J. J. Boza
Publikováno v:
European Journal of Pediatrics. 156:S50-S58
The central pathways of metabolism include glycolysis and gluconeogenesis, fatty acid synthesis and beta-oxidation, the citric acid cycle and ureagenesis. Because these pathways intersect, changes in one pathway, due to inborn error or disease, affec
Autor:
I, Gouni-Berthold, H K, Berthold
Publikováno v:
Handbook of experimental pharmacology. (214)
There is evidence that female patients receive less intensified drug therapy in many medical conditions than male patients. However, there are only limited data regarding the influence of physician gender on drug therapy. It has been shown, for examp
Autor:
H. K. Berthold, I. Gouni-Berthold
Publikováno v:
Sex and Gender Differences in Pharmacology ISBN: 9783642307256
There is evidence that female patients receive less intensified drug therapy in many medical conditions than male patients. However, there are only limited data regarding the influence of physician gender on drug therapy. It has been shown, for examp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e15574be941e5baad280425ffcb5d00b
https://doi.org/10.1007/978-3-642-30726-3_10
https://doi.org/10.1007/978-3-642-30726-3_10
Autor:
H K, Berthold
Publikováno v:
Zeitschrift fur Gerontologie und Geriatrie. 45(6)
New oral anticoagulants for the prevention of stroke in patients with nonvalvular atrial fibrillation have been available for a few months, among them the reversible direct thrombin inhibitor dabigatran and the factor Xa antagonist rivaroxaban. These